Supreme Court seems likely to preserve access to the abortion medication mifepristone

Contributing sentiments towards policy:

64% : Anti-abortion doctors and medical organizations argue that the FDA's decisions in 2016 and 2021 to relax restrictions on getting the drug were unreasonable and "jeopardize women's health across the nation."
54% : Solicitor General Elizabeth Prelogar, the Biden administration's top Supreme Court lawyer, said the court should make clear that the anti-abortion doctors and organizations that challenged the FDA's relaxation of restrictions on mifepristone don't "come within 100 miles" of having the legal right, or standing, to sue.
50% : That ruling had immediate political consequences, and the outcome in the new case, expected by early summer, could affect races for Congress and the White House.
43% : Health care providers have said that if mifepristone is no longer available or is too hard to obtain, they would switch to using only misoprostol, which is somewhat less effective in ending pregnancies.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.